Both in Biotechnology
Protalix BioTherapeutics vs Cabaletta Bio
Over the past year PLX returned +8.1% and CABA returned −40.5%; their daily moves had a correlation of 0.18.
PLX +8.1% CABA −40.5%Growth of $1, one year, split-adjusted
| Metric | PLX | CABA |
|---|---|---|
| Price | $2.55 | $1.47 |
| Market cap | $205.5M | $249.2M |
| Today | −0.78% | −3.29% |
| 1 month | −7.3% | −31.8% |
| 6 months | +17.0% | −50.2% |
| Year to date | +41.7% | −32.9% |
| 1 year | +12.3% | −40.0% |
| Revenue growth (YoY) | +27.1% | — |
| Gross margin | 61.0% | — |
| Net margin | 19.0% | — |
| P/E (TTM) | 10.8× | — |
| Price / sales | 2.5× | — |
| Net cash | $40.7M | $205.1M |
| Dividend yield | — | — |
| Volatility (60d) | 45.4% | 73.6% |
| Short % of float | 4.1% | 27.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).